Healio brings you the highlights from Transcatheter Cardiovascular Therapeutics. Refer back to this page often for the latest news from TCT, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

CRF announces late-breaking clinical trials for upcoming TCT meeting

September 17, 2017
The Cardiovascular Research Foundation released the lineup of lineup of Late-breaking Clinical Trials and First Report Investigations scheduled for…
Meeting News

Second-generation robotic system yields benefits for operators

December 6, 2016
WASHINGTON — At TCT 2016, Corindus Vascular Robotics demonstrated a second-generation vascular robotic system for PCI, which recently received…
Meeting News

Ultrasound system shows efficacy in treating all lesion lengths, vessel sizes in CLI

December 2, 2016
WASHINGTON — Among patients with critical limb ischemia, the use of percutaneous catheter-delivered ultrasound and paclitaxel offers ease of…
Meeting News

ENDURE: Next-generation DCB shows promise in patients with PAD

December 1, 2016
WASHINGTON — Among patients with peripheral artery disease, a second-generation drug-coated balloon appears to yield positive safety and…
Meeting News

ABSORB II fails to meet 3-year primary endpoints

November 29, 2016
WASHINGTON — A bioresorbable vascular scaffold did not meet its coprimary endpoint of noninferior late luminal loss or its mechanistic…
Meeting News

Early feasibility studies offer new opportunities for interventionalists, but challenges remain

November 17, 2016
WASHINGTON — Early feasibility studies are reviving device innovation in the United States, and offer several clinical advantages, as well as…
Meeting News

ILLUMENATE: DCB superior to angioplasty alone for SFA

November 11, 2016
WASHINGTON — In the ILLUMENATE trial, both safety and effectiveness endpoints demonstrated superiority of a drug-coated balloon over…
Meeting News

RevElution: Drug-filled stent signals favorable early healing profile

November 10, 2016
WASHINGTON — In the RevElution study, a polymer-free drug-filled stent met the primary endpoint of in-stent late lumen loss at 9 months…
Meeting News

SENTINEL: Embolic protection device for use during TAVR safe, but efficacy not yet proven

November 9, 2016
WASHINGTON — Although a transcatheter embolic protection device was safe, the primary endpoints of the SENTINEL study were not met, according…
Meeting NewsVideo

VIDEO: Trial of embolic protection during TAVR confirms need for further study

November 8, 2016
WASHINGTON — In this video, Patrick T. O’Gara, MD, MACC, past president of the American College of Cardiology and director of clinical…

Meeting Calendar

Transcatheter Cardiovascular Therapeutics

October 29, 2017 - November 2, 2017